Literature DB >> 29116635

Antigenic Variation and Immune Escape in the MTBC.

Joel D Ernst1.   

Abstract

Microbes that infect other organisms encounter host immune responses, and must overcome or evade innate and adaptive immune responses to successfully establish infection. Highly successful microbial pathogens, including M. tuberculosis, are able to evade adaptive immune responses (mediated by antibodies and/or T lymphocytes) and thereby establish long-term chronic infection. One mechanism that diverse pathogens use to evade adaptive immunity is antigenic variation, in which structural variants emerge that alter recognition by established immune responses and allow those pathogens to persist and/or to infect previously-immune hosts. Despite the wide use of antigenic variation by diverse pathogens, this mechanism appears to be infrequent in M. tuberculosis, as indicated by findings that known and predicted human T cell epitopes in this organism are highly conserved, although there are exceptions. These findings have implications for diagnostic tests that are based on measuring host immune responses, and for vaccine design and development.

Entities:  

Keywords:  Antigenic variation, Immune Escape, T lymphocytes, Epitopes, Antibodies, Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 29116635      PMCID: PMC5718154          DOI: 10.1007/978-3-319-64371-7_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  119 in total

1.  Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

Authors:  J A Caminero; M J Pena; M I Campos-Herrero; J C Rodríguez; O Afonso; C Martin; J M Pavón; M J Torres; M Burgos; P Cabrera; P M Small; D A Enarson
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.

Authors:  Sophie A Valkenburg; Sergio Quiñones-Parra; Stephanie Gras; Naomi Komadina; Jodie McVernon; Zhongfang Wang; Hanim Halim; Pina Iannello; Catherine Cole; Karen Laurie; Anne Kelso; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells.

Authors:  W D Hardt; L M Chen; K E Schuebel; X R Bustelo; J E Galán
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing.

Authors:  Christopher N LaRock; Simon Döhrmann; Jordan Todd; Ross Corriden; Joshua Olson; Timo Johannssen; Bernd Lepenies; Richard L Gallo; Partho Ghosh; Victor Nizet
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

5.  Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection.

Authors:  Robert Blomgran; Joel D Ernst
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

6.  Coxiella burnetii effector CvpB modulates phosphoinositide metabolism for optimal vacuole development.

Authors:  Eric Martinez; Julie Allombert; Franck Cantet; Anissa Lakhani; Naresh Yandrapalli; Aymeric Neyret; Isobel H Norville; Cyril Favard; Delphine Muriaux; Matteo Bonazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

7.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

8.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

9.  The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin.

Authors:  Bargavi Thyagarajan; Jesse D Bloom
Journal:  Elife       Date:  2014-07-08       Impact factor: 8.140

10.  Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-08-07       Impact factor: 17.586

View more
  11 in total

1.  Group A Streptococcus T Antigens Have a Highly Conserved Structure Concealed under a Heterogeneous Surface That Has Implications for Vaccine Design.

Authors:  Paul G Young; Jeremy M Raynes; Jacelyn M Loh; Thomas Proft; Edward N Baker; Nicole J Moreland
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 2.  Host-directed immunotherapy of viral and bacterial infections: past, present and future.

Authors:  Robert S Wallis; Anne O'Garra; Alan Sher; Andreas Wack
Journal:  Nat Rev Immunol       Date:  2022-06-07       Impact factor: 108.555

3.  Maximum antigen diversification in a lyme bacterial population and evolutionary strategies to overcome pathogen diversity.

Authors:  Lia Di; Saymon Akther; Edgaras Bezrucenkovas; Larisa Ivanova; Brian Sulkow; Bing Wu; Saad Mneimneh; Maria Gomes-Solecki; Wei-Gang Qiu
Journal:  ISME J       Date:  2021-08-19       Impact factor: 10.302

Review 4.  The Immune Escape Mechanisms of Mycobacterium Tuberculosis.

Authors:  Weijie Zhai; Fengjuan Wu; Yiyuan Zhang; Yurong Fu; Zhijun Liu
Journal:  Int J Mol Sci       Date:  2019-01-15       Impact factor: 6.208

5.  Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Authors:  Anja Scholzen; Guilhem Richard; Leonard Moise; Laurie A Baeten; Patrick M Reeves; William D Martin; Timothy A Brauns; Christine M Boyle; Susan Raju Paul; Richard Bucala; Richard A Bowen; Anja Garritsen; Anne S De Groot; Ann E Sluder; Mark C Poznansky
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

Review 6.  Immunoinformatics and Vaccine Development: An Overview.

Authors:  Angus Nnamdi Oli; Wilson Okechukwu Obialor; Martins Ositadimma Ifeanyichukwu; Damian Chukwu Odimegwu; Jude Nnaemeka Okoyeh; George Ogonna Emechebe; Samson Adedeji Adejumo; Gordon C Ibeanu
Journal:  Immunotargets Ther       Date:  2020-02-26

7.  Tandem Mass Tag-Based Quantitative Proteomics and Virulence Phenotype of Hemolymph-Treated Bacillus thuringiensis kurstaki Cells Reveal New Insights on Bacterial Pathogenesis in Insects.

Authors:  Yanyan Sun; Linlin Yang; Lianet Rodríguez-Cabrera; Yushan Ding; Chaoliang Leng; Huili Qiao; Siliang Huang; Yunchao Kan; Lunguang Yao; Denis J Wright; Dandan Li; Camilo Ayra-Pardo
Journal:  Microbiol Spectr       Date:  2021-10-27

8.  STAT1 and its related molecules as potential biomarkers in Mycobacterium tuberculosis infection.

Authors:  Xing-Hao Yi; Bo Zhang; Yu-Rong Fu; Zheng-Jun Yi
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

9.  Mapping Gene-by-Gene Single-Nucleotide Variation in 8,535 Mycobacterium tuberculosis Genomes: a Resource To Support Potential Vaccine and Drug Development.

Authors:  Matthew K O'Shea; Alan McNally; Danai Papakonstantinou; Steven J Dunn; Simon J Draper; Adam F Cunningham
Journal:  mSphere       Date:  2021-03-10       Impact factor: 4.389

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.